Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Synthesis and antimalarial and anticancer evaluation of 7-chlorquinoline-4-thiazoleacetic derivatives containing aryl hydrazide moieties

H. Ramírez, E. Fernandez, J. Rodrigues, S. Mayora, G. Martínez, C. Celis, JB. De Sanctis, M. Mijares, J. Charris

. 2021 ; 354 (7) : e2100002. [pub] 20210304

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22004109

Twelve 7-chloroquinoline derivatives were designed and synthesized using the principle of molecular hybridization through the coupling of 2-[2-(7-chloroquinolin-4-ylthio)-4-methylthiazol-5-yl]acetic acid 1 with various benzoyl hydrazines 2a-l. The synthetic compounds were tested as antimalarials. Some of them showed an efficient in vitro activity as inhibitors of β-hematin formation and an in vivo activity in a murine model, resulting in compounds 8 and 9 as the most active ones with IC50 values of 0.65 ± 0.09 and 0.64 ± 0.16 µM, respectively. The effects of the compounds on the cell viability, cell cycle, and apoptosis induction of A549 and MCF-7 cancer cell lines were also examined. Our data showed that compounds 6 and 12 were the most active agents, decreasing the cell viability of MCF-7 cells with IC50 values of 15.41 and 12.99 µM, respectively. None of the compounds analyzed significantly affected the viability of peripheral blood mononuclear cells. Also, significant induction of apoptosis was observed when both cancer cell lines were incubated with compounds 6 and 12. In MCF-7 cells, treatment with these compounds led to cell cycle arrest in the G0/G1 phase. The results obtained suggest that these structures may be useful in developing new therapies for malaria and cancer treatment.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22004109
003      
CZ-PrNML
005      
20220127145524.0
007      
ta
008      
220113s2021 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1002/ardp.202100002 $2 doi
035    __
$a (PubMed)33660349
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Ramírez, Hegira $u Organic Synthesis Laboratory, Faculty of Pharmacy, Central University of Venezuela, Caracas, Venezuela $u Facultad de Medicina, Universidad de Las Américas, Quito, Ecuador
245    10
$a Synthesis and antimalarial and anticancer evaluation of 7-chlorquinoline-4-thiazoleacetic derivatives containing aryl hydrazide moieties / $c H. Ramírez, E. Fernandez, J. Rodrigues, S. Mayora, G. Martínez, C. Celis, JB. De Sanctis, M. Mijares, J. Charris
520    9_
$a Twelve 7-chloroquinoline derivatives were designed and synthesized using the principle of molecular hybridization through the coupling of 2-[2-(7-chloroquinolin-4-ylthio)-4-methylthiazol-5-yl]acetic acid 1 with various benzoyl hydrazines 2a-l. The synthetic compounds were tested as antimalarials. Some of them showed an efficient in vitro activity as inhibitors of β-hematin formation and an in vivo activity in a murine model, resulting in compounds 8 and 9 as the most active ones with IC50 values of 0.65 ± 0.09 and 0.64 ± 0.16 µM, respectively. The effects of the compounds on the cell viability, cell cycle, and apoptosis induction of A549 and MCF-7 cancer cell lines were also examined. Our data showed that compounds 6 and 12 were the most active agents, decreasing the cell viability of MCF-7 cells with IC50 values of 15.41 and 12.99 µM, respectively. None of the compounds analyzed significantly affected the viability of peripheral blood mononuclear cells. Also, significant induction of apoptosis was observed when both cancer cell lines were incubated with compounds 6 and 12. In MCF-7 cells, treatment with these compounds led to cell cycle arrest in the G0/G1 phase. The results obtained suggest that these structures may be useful in developing new therapies for malaria and cancer treatment.
650    _2
$a buňky A549 $7 D000072283
650    _2
$a kyselina octová $x chemická syntéza $x chemie $x farmakologie $7 D019342
650    _2
$a zvířata $7 D000818
650    _2
$a antimalarika $x chemická syntéza $x chemie $x farmakologie $7 D000962
650    _2
$a protinádorové látky $x chemická syntéza $x chemie $x farmakologie $7 D000970
650    _2
$a apoptóza $x účinky léků $7 D017209
650    _2
$a kontrolní body buněčného cyklu $x účinky léků $7 D059447
650    _2
$a viabilita buněk $x účinky léků $7 D002470
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a lidé $7 D006801
650    _2
$a hydraziny $x chemická syntéza $x chemie $x farmakologie $7 D006834
650    _2
$a inhibiční koncentrace 50 $7 D020128
650    _2
$a MFC-7 buňky $7 D061986
650    _2
$a malárie $x farmakoterapie $7 D008288
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední BALB C $7 D008807
650    _2
$a chinoliny $x chemická syntéza $x chemie $x farmakologie $7 D011804
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
650    _2
$a thiazoly $x chemická syntéza $x chemie $x farmakologie $7 D013844
655    _2
$a časopisecké články $7 D016428
700    1_
$a Fernandez, Esteban $u Facultad de Medicina, Universidad de Las Américas, Quito, Ecuador
700    1_
$a Rodrigues, Juan $u Departamento de Tecnología de Procesos Biológicos y Bioquímicos, División de Ciencias Biológicas, Universidad Simón Bolívar, Caracas, Venezuela
700    1_
$a Mayora, Soriuska $u Biotechnology Unit, Faculty of Pharmacy, Central University of Venezuela, Caracas, Venezuela $u Institute of Immunology, Faculty of Medicine, Central University of Venezuela, Caracas, Venezuela
700    1_
$a Martínez, Gricelis $u Institute of Immunology, Faculty of Medicine, Central University of Venezuela, Caracas, Venezuela
700    1_
$a Celis, Carmen $u Biotechnology Unit, Faculty of Pharmacy, Central University of Venezuela, Caracas, Venezuela
700    1_
$a De Sanctis, Juan B $u Institute of Immunology, Faculty of Medicine, Central University of Venezuela, Caracas, Venezuela $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
700    1_
$a Mijares, Michael $u Biotechnology Unit, Faculty of Pharmacy, Central University of Venezuela, Caracas, Venezuela $u Institute of Immunology, Faculty of Medicine, Central University of Venezuela, Caracas, Venezuela
700    1_
$a Charris, Jaime $u Organic Synthesis Laboratory, Faculty of Pharmacy, Central University of Venezuela, Caracas, Venezuela
773    0_
$w MED00000507 $t Archiv der Pharmazie $x 1521-4184 $g Roč. 354, č. 7 (2021), s. e2100002
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33660349 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127145521 $b ABA008
999    __
$a ok $b bmc $g 1751539 $s 1155258
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 354 $c 7 $d e2100002 $e 20210304 $i 1521-4184 $m Archiv der Pharmazie $n Arch Pharm $x MED00000507
LZP    __
$a Pubmed-20220113

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...